| Literature DB >> 25402479 |
Mary M Christopher1, Michelle G Hawkins2, Andrew G Burton3.
Abstract
Rabbits (Oryctolagus cuniculus) are a popular companion animal, food animal, and animal model of human disease. Abnormal red cell shapes (poikilocytes) have been observed in rabbits, but their significance is unknown. The objective of this study was to investigate the prevalence and type of poikilocytosis in pet rabbits and its association with physiologic factors, clinical disease, and laboratory abnormalities. We retrospectively analyzed blood smears from 482 rabbits presented to the University of California-Davis Veterinary Medical Teaching Hospital from 1990 to 2010. Number and type of poikilocytes per 2000 red blood cells (RBCs) were counted and expressed as a percentage. Acanthocytes (>3% of RBCs) were found in 150/482 (31%) rabbits and echinocytes (>3% of RBCs) were found in 127/482 (27%) of rabbits, both healthy and diseased. Thirty-three of 482 (7%) rabbits had >30% acanthocytes and echinocytes combined. Mild to moderate (>0.5% of RBCs) fragmented red cells (schistocytes, microcytes, keratocytes, spherocytes) were found in 25/403 (6%) diseased and 0/79 (0%) healthy rabbits (P = 0.0240). Fragmentation and acanthocytosis were more severe in rabbits with inflammatory disease and malignant neoplasia compared with healthy rabbits (P<0.01). The % fragmented cells correlated with % polychromasia, RDW, and heterophil, monocyte, globulins, and fibrinogen concentrations (P<0.05). Echinocytosis was significantly associated with renal failure, azotemia, and acid-base/electrolyte abnormalities (P<0.05). Serum cholesterol concentration correlated significantly with % acanthocytes (P<0.0001), % echinocytes (P = 0.0069), and % fragmented cells (P = 0.0109), but correlations were weak (Spearman ρ <0.02). These findings provide important insights into underlying pathophysiologic mechanisms that appear to affect the prevalence and type of naturally-occurring poikilocytosis in rabbits. Our findings support the need to carefully document poikilocytes in research investigations and in clinical diagnosis and to determine their diagnostic and prognostic value.Entities:
Mesh:
Year: 2014 PMID: 25402479 PMCID: PMC4234375 DOI: 10.1371/journal.pone.0112455
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Poikilocytes in blood smears from rabbits.
(A) Acanthocytes (arrows) in a healthy rabbit; (B) echinocytes in a rabbit with renal failure; (C) schistocytes (closed arrowheads) in a rabbit with a dental abscess; and (D) spherocytes (open arrowhead) and schistocytes (open arrows) in a rabbit with a mandibular abscess. Wright-Giemsa stain. Scale bar = 10 µm.
Figure 3Dot plots of % poikilocytes in samples from healthy (n = 79) and diseased (n = 403) rabbits.
Significant differences between healthy and diseased rabbits were observed for % schistocytes, % keratocytes, % microcytes, and % total fragmented cells (P<.05, Wilcoxon).
Figure 2Prevalence of poikilocytes in 492 rabbits.
Fragmented cells include schistocytes, keratocytes, microcytes, and spherocytes.
Primary diagnosis by organ system for the 482 rabbits in the study (1990 to 2010).
| Organ System | Disease | Clinical Diagnosis | Pathology Diagnosis | Total |
| Bone and joint | Fracture | 14 | 0 | 14 |
| Degenerative joint disease | 5 | 2 | 7 | |
| Luxation | 2 | 0 | 2 | |
| Neoplasia (sarcoma, squamous cell carcinoma) | 0 | 2 | 2 | |
| Other (lameness, multifocal bony lesions) | 2 | 0 | 2 | |
| Cardiovascular | Myxomatous valve degeneration | 2 | 1 | 3 |
| Cardiomyopathy | 1 | 1 | 2 | |
| Arrythmia | 1 | 0 | 1 | |
| Dental | Malocclusion/periodontitis | 37 | 1 | 38 |
| Mandibular abscessation/osteomyelitis | 29 | 9 | 38 | |
| Gastrointestinal | GI stasis | 25 | 0 | 25 |
| Enteritis/gastritis/typhylitis/colitis | 2 | 9 | 11 | |
| Diarrhea | 5 | 0 | 5 | |
| Trichobezoar | 0 | 3 | 3 | |
| Abscess | 1 | 1 | 2 | |
| Neoplasia (papilloma, adenocarcinoma) | 0 | 2 | 2 | |
| Other (dysbiosis, cecal impaction) | 4 | 0 | 4 | |
| Hemolymphatic | Mediastinal thymoma | 2 | 2 | 4 |
| Lymphoma | 0 | 3 | 3 | |
| Regenerative anemia | 1 | 0 | 1 | |
| Hepatic | Enzymopathy | 4 | 0 | 4 |
| Hepatitis/cholangiohepatitis | 0 | 3 | 3 | |
| Torsion with necrosis | 0 | 2 | 2 | |
| Neoplasia (cystadenocarcinoma) | 0 | 1 | 1 | |
| Neurologic | Encephalitozoonosis | 0 | 6 | 6 |
| Ataxia/paresis/paralysis | 6 | 0 | 6 | |
| Myelopathy | 5 | 0 | 5 | |
| Vestibular disease | 3 | 0 | 3 | |
| CNS disease | 3 | 0 | 3 | |
| Neoplasia (pineocytoma) | 0 | 1 | 1 | |
| Bacterial meningoencephalitis | 0 | 1 | 1 | |
| Brain hemorrhage | 0 | 1 | 1 | |
| Other (lumbosacral disease, seizures, head trauma) | 3 | 0 | 3 | |
| Ophthalmic | Keratitis/uveitis/ulcer | 8 | 0 | 8 |
| Glaucoma/cataracts | 5 | 0 | 5 | |
| Chemosis/conjunctivitis | 5 | 0 | 5 | |
| Dacryocystitis | 5 | 0 | 5 | |
| Iris granuloma | 3 | 0 | 3 | |
| Other (corneal fibrosis, laceration, dystrichia, epicorneal membrane) | 4 | 0 | 4 | |
| Reproductive | Uterine disease (endometritis, cysts, hydrometra, mass, varices) | 4 | 1 | 5 |
| Neoplasia (testicular granular cell tumor) | 0 | 1 | 1 | |
| Respiratory | Upper respiratory tract disease | 20 | 3 | 23 |
| Bronchopneumonia | 3 | 5 | 8 | |
| Lung abscessation+pneumonia | 0 | 4 | 4 | |
| Neoplasia (carcinoma, granular cell tumor) | 0 | 2 | 2 | |
| Other (nasal mass, lung consolidation, stridor) | 3 | 0 | 3 | |
| Skin/subcutis | Otitis | 13 | 1 | 14 |
| Cellulitis (bite wounds, myiasis) | 7 | 3 | 10 | |
| Dermatitis, nonparasitic | 9 | 5 | 14 | |
| Dermatitis, parasitic | 10 | 0 | 10 | |
| Pododermatitis | 6 | 0 | 6 | |
| Abscess, soft tissue | 3 | 3 | 6 | |
| Laceration | 6 | 0 | 6 | |
| Neoplasia, malignant (sarcoma, squamous cell carcinoma) | 0 | 7 | 7 | |
| Neoplasia, benign (lipoma, polyp) | 1 | 2 | 3 | |
| Other (myositis/fibrosis, cutaneous mass) | 3 | 0 | 3 | |
| Urinary | Renal failure | 7 | 7 | 14 |
| Urolithiasis | 8 | 0 | 8 | |
| Urine sludge | 7 | 0 | 7 | |
| Cystitis | 4 | 0 | 4 | |
| Other | Anorexia, weight loss | 5 | 0 | 5 |
| Abdominal mass | 1 | 0 | 1 | |
| Hypercalcemia | 1 | 0 | 1 |
The proportion of rabbits with specific diseases having moderate to marked acanthocytosis or echinocytosis and mild to moderate fragmentation as compared with healthy rabbits.
| Disease | Clinical Diagnosis | Pathologic Diagnosis | AcanthocytosisMod-Mkd | EchinocytosisMod-Mkd | FragmentationMild-Mod |
| Abscess | 32 | 18 | 26/50 (52%)** | 14/50 (28%) | 7/50 (14%)*** |
| Bronchopneumonia | 3 | 9 | 8/12 (67%) | 3/12 (25%) | 1/12 (8%)** |
| Cellulitis | 7 | 3 | 7/10 (70%)** | 4/10 (40%) | 2/10 (20%)*** |
| Dental (non-abscess) | 37 | 1 | 11/38 (29%) | 14/38 (36%) | 2/38 (5%) |
| Dermatitis | 19 | 5 | 5/24 (21%) | 6/24 (25%) | 1/24 (4%) |
| Fracture | 12 | 2 | 3/14 (21%) | 2/14 (14%) | 0/14 (0%) |
| GI inflammation | 2 | 9 | 4/11 (36%) | 2/11 (18%) | 1/11 (9%)** |
| GI stasis | 25 | 0 | 5/25 (20%) | 6/25 (24%) | 0/25 (0%) |
| Neoplasia, malignant | 0 | 22 | 5/22 (22%) | 3/22 (14%) | 2/22 (9%)** |
| Otitis | 13 | 1 | 3/14 (21%) | 3/14 (21%) | 0/14 (0%) |
| Renal failure | 7 | 7 | 4/14 (28%) | 8/14 (57%) | 1/14 (7%) |
| URTD | 20 | 3 | 7/23 (30%) | 7/23 (30%) | 0/23 (0%) |
| Healthy | 79 | 0 | 23/79 (29%) | 19/79 (24%) | 0/79 (0%) |
*P<.05; **P<.01; ***P<.001.
Four rabbits with bronchopneumonia also had lung abscessation; 4 had confirmed sepsis.
Eight of 10 cases of cellulitis were septic (myiasis or bacterial); GI inflammation was septic in 7/11 cases (5 with intralesional bacteria, 1 with Coccidia, 1 with Coccidia and Giardia.
Two rabbits with renal failure also had pneumonia.
GI indicates gastrointestinal; URTD indicates upper respiratory tract disease.
Hematologic and biochemical values (mean ± SEM) in 482 rabbits based on severity of poikilocytosis.
| Analyte | Acanthocytosis | Echinocytosis | Fragmentation | ||||||
| Moderate-marked | None-mild | P value | Moderate-marked | None-mild | P value | Mild-moderate | None-rare | P value | |
| RBC (X106/µl) | 5.8±0.1 | 5.8±0.1 | – | 6.0±0.1 | 5.7±0.1 | 0.0055 | 5.3±0.2 | 5.8±0.1 | 0.0241 |
| HCT (%) | 36.7±0.5 | 37.2±0.3 | – | 38.5±0.5 | 36.6±0.3 | 0.0012 | 34.3±1.1 | 37.2±0.2 | 0.0124 |
| HGB (g/dl) | 12.3±0.1 | 12.5±0.1 | – | 12.9±0.2 | 12.3±0.1 | 0.0055 | 11.1±0.4 | 12.5±0.1 | 0.0006 |
| MCV (fl) | 63.7±0.3 | 64.6±0.2 | 0.0454 | 64.6±0.3 | 64.2±0.2 | – | 65.3±0.8 | 64.3±0.2 | – |
| MCH (pg) | 21.4±0.1 | 21.7±0.1 | – | 21.5±0.1 | 21.6±0.1 | – | 20.9±0.3 | 21.6±0.1 | 0.0243 |
| MCHC (g/dl) | 33.6±0.1 | 33.6±0.1 | – | 33.4±0.1 | 33.7±0.1 | – | 32.1±0.3 | 33.7±0.1 | <0.0001 |
| RDW (%) | 13.8±0.1 | 13.2±0.1 | 0.0008 | 13.4±0.1 | 13.4±0.1 | – | 16.1±0.3 | 13.3±0.1 | <0.0001 |
| POLY (%) | 1.3±0.1 | 1.2±0.04 | – | 1.3±0.1 | 1.2±0.04 | – | 1.8±0.1 | 1.2±0.03 | 0.0002 |
| WBC (/µl) | 7677±264 | 7509±178 | – | 8036±287 | 7393±171 | – | 8493±646 | 7510±151 | – |
| HET (/µl) | 3780±211 | 3663±142 | – | 4022±230 | 3585±137 | – | 4914±515 | 3632±120 | 0.0159 |
| LYM (/µl) | 2940±143 | 2970±96 | – | 3008±156 | 2944±93 | – | 2562±351 | 2983±82 | – |
| MONO (/µl) | 525±38 | 510±26 | – | 606±41 | 483±24 | 0.0116 | 679±94 | 506±22 | – |
| EOS (/µl) | 89±8 | 84±5 | – | 80±8 | 88±5 | – | 81±19 | 86±4 | – |
| BASO (/µl) | 314±19 | 261±13 | 0.0226 | 278±21 | 277±12 | – | 238±47 | 280±11 | – |
| PLT (X103/µl) | 630±25 | 579±16 | – | 609±27 | 588±15 | – | 764±62 | 586±13 | 0.0057 |
| MPV (fl) | 7.4±0.2 | 7.2±0.1 | – | 7.7±0.2 | 7.1±0.1 | 0.0105 | 8.4±0.5 | 7.2±0.1 | 0.0228 |
| TPP (g/dl) | 7.2±0.1 | 7.1±0.04 | – | 7.3±0.1 | 7.1±0.1 | – | 7.1±0.1 | 7.2±0.04 | – |
| FIB (mg/dl) | 303±16 | 312±10 | – | 340±17 | 298±10 | 0.0377 | 408±38 | 304±9 | 0.0076 |
| AG (mmol/L) | 25.4±0.6 | 24.8±0.4 | – | 27.1±0.6 | 24.1±0.4 | 0.0001 | 26.3±1.7 | 25.0±0.3 | – |
| Na (mmol/L) | 144.0±0.4 | 143.6±0.2 | – | 144.6±0.4 | 143.4±0.2 | 0.0079 | 143.2±1.0 | 143.8±0.2 | – |
| K (mmol/L) | 4.6±0.1 | 4.4±0.1 | 0.0202 | 4.6±0.1 | 4.4±0.1 | 0.0271 | 5.0±0.2 | 4.4±0.04 | 0.0077 |
| Cl (mmol/L) | 102.9±0.4 | 102.5±0.3 | – | 103.6±0.5 | 102.3±0.3 | 0.0246 | 102.8±1.2 | 102.6±0.2 | – |
| HCO3 (mmol/L) | 20.3±0.5 | 20.9±0.3 | – | 18.5±0.4 | 21.6±0.3 | <0.0001 | 19.1±1.2 | 20.8±0.2 | – |
| CA (mg/dl) | 14.7±0. 1 | 14.4±0.1 | – | 14.5±0.1 | 14.5±0.1 | – | 14.2±0.3 | 14.5±0.1 | – |
| PHOS (mg/dl) | 3.6±0.2 | 3.7±0.1 | – | 4.0±0.2 | 3.5±0.1 | 0.0331 | 3.5±0.5 | 3.7±0.1 | – |
| BUN (mg/dl) | 24.3±2.0 | 23.2±1.3 | – | 26.7±2.1 | 22.4±1.3 | – | 29.1±5.0 | 23.3±1.1 | – |
| CREA (mg/dl) | 1.3±0.1 | 1.4±0.1 | – | 1.7±0.1 | 1.3±0.1 | 0.0148 | 1.6±0.3 | 1.4±0.1 | – |
| GLU (mg/dl) | 164.7±4.0 | 166.4±2.7 | – | 158.3±4.3 | 168.6±2.6 | 0.0424 | 146.2±10.2 | 166.8±2.3 | 0.0482 |
| T. PROT (g/dl) | 7.3±0.2 | 6.9±0.1 | – | 7.0±0.2 | 7.1±0.1 | – | 6.9±0.5 | 7.1±0.1 | – |
| ALB (g/dl) | 5.3±0.1 | 5.2±0.1 | – | 5.1±0.1 | 5.2±0.1 | – | 4.4±0.2 | 5.3±0.04 | <0.0001 |
| GLOB (g/dl) | 1.7±0.1 | 1.97±0.1 | – | 1.9±0.1 | 1.7±0.1 | – | 2.5±0.2 | 1.7±0.05 | 0.0010 |
| CHOL (mg/dl) | 58.1±3.9 | 43.5±2.6 | 0.0044 | 57.3±4.2 | 44.3±2.6 | 0.0094 | 93.5±9.9 | 45.6±2.2 | <0.0001 |
| T. BILI (mg/dl) | 0.1±0.1 | 0.2±0.1 | – | 0.1±0.1 | 0.2±0.1 | – | 0.1±0.2 | 0.2±0.1 | – |
| ALT (U/L) | 50±17 | 81±11 | – | 57±18 | 77±11 | – | 66±44 | 71±10 | – |
| AST (U/L) | 44±62 | 129±42 | – | 64±67 | 116±41 | – | 63±159 | 104±36 | – |
| ALP (U/L) | 62±8 | 77±6 | – | 60±9 | 77±6 | – | 87±22 | 71±5 | – |
| CK (U/L) | 1244±430 | 2198±298 | – | 2429±465 | 1680±289 | – | 6567±1110 | 1658±246 | <0.0001 |
| GGT (U/L) | 10±2 | 12±1 | – | 11±2 | 11±1 | – | 19±5 | 11±1 | – |
| N | 118–150 | 245–332 | – | 101–127 | 262–355 | – | 16–25 | 346–457 | – |
*Student’s t test between rabbits having moderate-marked (>3% of RBCs) vs none-mild (≤3% of RBCs) acanthocytes or echinocytes, or mild-moderate (>0.5% of RBCs) vs none-rare (≤0.5% of RBCs) fragmented red cells.
– indicates no significant difference.
Figure 4Principal component analysis of % poikilocytes and selected laboratory values.
Two primary components were identified, in the right upper (component 2) and right lower (component 1) quadrants. The longer the arrow, the stronger the correlation. Analytes in left quadrants are negatively correlated with those in the diagonal quadrant.